DARE
Dare Bioscience, Inc.
+0.03 (+4.52%)0.76USD81.9K成交股數11.6M市值–本益比(近四季)8.6股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 188K | 152K+500% | – | 2K-90% | – | 25K-99% | 42K-96% | 22K | 9K | 1.8M | 1.0M | 0.00 |
| 營業成本 | 320K | 242K | – | – | 0.00 | 0.00 | – | – | – | – | – | – |
| 毛利 | −132K | −90K-453% | – | – | – | 25K | – | – | – | – | – | – |
| 毛利率 | -70.6% | -58.9% | – | – | – | 100.0% | – | – | – | – | – | – |
| 研發費用 | 242K | 660K | 622K | 1.2M | 1.4M | 2.3M | 2.7M | 4.9M | 3.4M | 3.8M | 6.7M | 6.0M |
| 銷售管理費用 | 2.6M | 2.2M | 1.6M | 2.5M | 2.4M | 2.3M | 2.0M | 2.4M | 2.7M | 3.2M | 2.7M | 2.9M |
| 營業利益 | −3.0M-22% | −3.0M-35% | −1.5M-69% | −3.7M-50% | −3.8M-36% | −4.6M-11% | −4.7M-44% | −7.4M-18% | −6.0M | −5.2M | −8.4M | −9.0M |
| 營業利益率 | -1,582.5% | -1,967.1% | – | -162,340.8% | – | -18,016.7% | -11,228.7% | -32,799.1% | -64,743.9% | -286.1% | -839.6% | – |
| 稅後淨利 | −3.0M-26% | −3.0M-31% | −1.4M-69% | −3.6M-128% | −4.0M-41% | −4.4M-13% | −4.7M-43% | 12.9M-247% | −6.8M | −5.1M | −8.3M | −8.8M |
| 淨利率 | -1,590.4% | -1,967.7% | – | -157,505.1% | – | -17,219.1% | -11,279.4% | 57,539.2% | -72,622.6% | -279.7% | -829.9% | – |
| 稀釋 EPS | -0.20-56% | -0.21-58% | 0.03-105% | -0.28-118% | -0.45-44% | -0.50-71% | -0.55-50% | 1.52-225% | -0.81 | -1.75 | -1.09 | -1.22 |
| 稀釋股數 | 14.9M | 14.5M | 11.2M | 12.8M | 8.9M | 8.8M | 8.5M | 8.5M | 8.4M | 7.3M | 7.6M | 7.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 12.6M | 18.5M | 24.7M | 23.1M | 5.0M | 10.3M | 11.2M | 16.4M | 3.6M | 10.5M | 13.9M | 13.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 22.4M | 27.8M | 32.5M | 30.7M | 13.0M | 18.6M | 18.1M | 23.6M | 13.0M | 21.3M | 25.1M | 23.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 22.9M | 27.1M | 29.6M | 27.9M | 25.7M | 28.2M | 19.5M | 20.9M | 24.0M | 26.3M | 27.3M | 25.9M |
| 股東權益 | −560K | 734K | 2.8M | 2.9M | −12.7M | −9.6M | −1.5M | 2.7M | −11.0M | −5.0M | −2.3M | −2.7M |
| 負債比 | 102.5% | 97.4% | 91.2% | 90.7% | 198.1% | 151.4% | 108.2% | 88.7% | 184.5% | 123.7% | 109.1% | 111.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.5M+1% | – | – | – | −5.5M | – | – | −6.8M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 157K | – | – | 7K | – | – | – |
| 自由現金流 | – | −5.5M-2% | – | – | – | −5.6M | – | – | −6.8M | – | – | – |
| 折舊攤銷 | – | 555K | – | – | – | 176K | – | – | 11K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -3,621.2% | – | – | – | -22,133.5% | – | – | -73,320.3% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.0M
| Reportable | 1.0M | 100.0% | +10429.4% |
|---|
產品／服務2025 年度 · 13.0M
| License And Collaboration Revenues | 12.0M | 92.1% | +9.1% |
|---|---|---|---|
| License | 1.0M | 7.9% | +10429.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.0M | +10429.4% | −13.4M | -1,300.7% | -1.20 | −10.3M |
| FY2024 | 10K | -99.7% | −4.1M | -41,394.1% | -0.48 | 4.9M |
| FY2023 | 2.8M | -71.9% | −30.2M | -1,074.1% | -4.15 | −39.5M |
| FY2022 | 10.0M | – | −30.9M | -309.5% | -0.37 | −18.2M |
| FY2021 | 0.00 | – | −38.7M | –% | -0.63 | −28.8M |
| FY2020 | – | – | −27.4M | –% | -0.91 | −25.3M |
| FY2019 | – | – | −14.3M | –% | -0.97 | −13.3M |
| FY2018 | – | – | −16.7M | –% | -1.57 | −10.3M |